Literature DB >> 29800117

Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sézary Syndrome.

Julia Dai1, Timothy H Almazan1, Eric K Hong1, Michael S Khodadoust2, Sally Arai3, Wen-Kai Weng1,3, Youn H Kim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29800117      PMCID： PMC6145646          DOI： 10.1001/jamadermatol.2018.0884

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent.

Authors:  J J Scarisbrick; F L Dignan; S Tulpule; E D Gupta; S Kolade; B Shaw; F Evison; G Shah; E Tholouli; G Mufti; A Pagliuca; R Malladi; K Raj
Journal:  Bone Marrow Transplant       Date:  2014-10-13       Impact factor: 5.483

2.  Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.

Authors:  Madeleine Duvic; Lauren C Pinter-Brown; Francine M Foss; Lubomir Sokol; Jeffrey L Jorgensen; Pramoda Challagundla; Karen M Dwyer; Xiaoping Zhang; Michael R Kurman; Rocco Ballerini; Li Liu; Youn H Kim
Journal:  Blood       Date:  2015-01-20       Impact factor: 22.113

3.  Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.

Authors:  Xiao Ni; Jeffrey L Jorgensen; Meghali Goswami; Pramoda Challagundla; William K Decker; Youn H Kim; Madeleine A Duvic
Journal:  Clin Cancer Res       Date:  2014-11-05       Impact factor: 12.531

4.  Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas.

Authors:  Adèle de Masson; Marie Beylot-Barry; Jean-David Bouaziz; Régis Peffault de Latour; François Aubin; Sylvain Garciaz; Michel d'Incan; Olivier Dereure; Stéphane Dalle; Anne Dompmartin; Felipe Suarez; Maxime Battistella; Marie-Dominique Vignon-Pennamen; Jacqueline Rivet; Henri Adamski; Pauline Brice; Sylvie François; Séverine Lissandre; Pascal Turlure; Ewa Wierzbicka-Hainaut; Eolia Brissot; Rémy Dulery; Sophie Servais; Aurélie Ravinet; Reza Tabrizi; Saskia Ingen-Housz-Oro; Pascal Joly; Gérard Socié; Martine Bagot
Journal:  Haematologica       Date:  2013-11-08       Impact factor: 9.941

5.  Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality.

Authors:  Shigeo Fuji; Yoshitaka Inoue; Atae Utsunomiya; Yukiyoshi Moriuchi; Kaoru Uchimaru; Ilseung Choi; Eiichi Otsuka; Hideho Henzan; Koji Kato; Takeaki Tomoyose; Hisashi Yamamoto; Saiko Kurosawa; Ken-Ichi Matsuoka; Takuhiro Yamaguchi; Takahiro Fukuda
Journal:  J Clin Oncol       Date:  2016-08-09       Impact factor: 44.544

6.  Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution.

Authors:  C Hosing; R Bassett; B Dabaja; R Talpur; A Alousi; S Ciurea; U Popat; M Qazilbash; E J Shpall; Y Oki; Y Nieto; C Pinnix; M Fanale; F Maadani; M Donato; R Champlin; M Duvic
Journal:  Ann Oncol       Date:  2015-09-28       Impact factor: 32.976
  6 in total
  1 in total

Review 1.  Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives.

Authors:  Malgorzata Bobrowicz; Radoslaw Zagozdzon; Joanna Domagala; Roberta Vasconcelos-Berg; Emmanuella Guenova; Magdalena Winiarska
Journal:  Cancers (Basel)       Date:  2019-09-24       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.